Decreased circulatory erythropoietin in hyperacute phase of myocardial ischemia


Alioglu E., Ercan E., Tamer G. S., Duman C., Turk U., Tengiz I., ...Daha Fazla

INTERNATIONAL JOURNAL OF CARDIOLOGY, cilt.146, sa.3, 2011 (SCI-Expanded) identifier identifier identifier

Özet

Purpose: Erythropoietin provides cellular protection by inhibiting apoptosis. Myocardial damage related to the cardiac ischemia is more prominent especially in the first 6 h. In the present study, circulatory erythropoietin levels in response to cardiac ischemia were evaluated.